{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:55:12Z","timestamp":1792814112213,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ajo.2023.11.003","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T09:19:22Z","timestamp":1699435162000},"page":"37-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Noninfectious Outcomes of Intravitreal Antibiotic Steroid Injection and Topical Nonsteroidal Antiinflammatory Drugs Versus Triple Drop Therapy After Cataract Surgery"],"prefix":"10.1016","volume":"260","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7039-0081","authenticated-orcid":false,"given":"Osamah T.","family":"Mian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9910-0014","authenticated-orcid":false,"given":"Hassaan","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1422-0130","authenticated-orcid":false,"given":"Karan","family":"Multani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim V.","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9475-437X","authenticated-orcid":false,"given":"Kai","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1090-5025","authenticated-orcid":false,"given":"Kamran M.","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ajo.2023.11.003_bib0001","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jama.2018.1150","article-title":"Health care spending in the united states and other high-income countries","volume":"319","author":"Papanicolas","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2023.11.003_bib0002","first-page":"18","article-title":"Noncompliance with prescribed eyedrop regimens among patients undergoing cataract surgery\u2014prevalence, consequences, and solutions","volume":"13","author":"Matossian","year":"2020","journal-title":"US Ophthalmic Rev"},{"issue":"11","key":"10.1016\/j.ajo.2023.11.003_bib0003","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jcrs.2014.02.037","article-title":"Evaluation of eyedrop administration by inexperienced patients after cataract surgery","volume":"40","author":"An","year":"2014","journal-title":"J Cataract Refract Surg"},{"issue":"8","key":"10.1016\/j.ajo.2023.11.003_bib0004","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1755-3768.2007.01155.x","article-title":"Self-application of single-use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients","volume":"86","author":"Dietlein","year":"2008","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2023.11.003_bib0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/j.jcrs.0000000000000833","article-title":"Fill levels, cost comparisons, and expulsion force requirements of commonly used topical ophthalmic steroids","volume":"48","author":"Gill","year":"2022","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"10.1016\/j.ajo.2023.11.003_bib0006","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10792-010-9362-3","article-title":"Electronic compliance monitoring of topical treatment after ophthalmic surgery","volume":"30","author":"Hermann","year":"2010","journal-title":"Int Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2023.11.003_bib0007","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2174\/1381612822666161129150628","article-title":"Dropless cataract surgery: an overview","volume":"23","author":"Lindstrom","year":"2017","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.ajo.2023.11.003_bib0008","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2016.09.027","article-title":"Cataract in the adult eye preferred practice pattern","volume":"124","author":"Olson","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2023.11.003_bib0009","unstructured":"National Institute for Health and Care Excellence. Cataracts in adults: Management. Available at https:\/\/www.nice.org.uk\/guidance\/ng77. Accessed June 18, 2023."},{"issue":"4","key":"10.1016\/j.ajo.2023.11.003_bib0010","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jcrs.2018.11.002","article-title":"Visual outcomes after cataract surgery in patients with type 2 diabetes","volume":"45","author":"Liu","year":"2019","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"10.1016\/j.ajo.2023.11.003_bib0011","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ophtha.2019.11.005","article-title":"Prescribing patterns and costs associated with postoperative eye drop use in Medicare beneficiaries undergoing cataract surgery","volume":"127","author":"Zafar","year":"2020","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2023.11.003_bib0012","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2021.10.006","article-title":"Cataract in the adult eye preferred practice pattern","volume":"129","author":"Miller","year":"2022","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2023.11.003_bib0013","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jcrs.2007.02.032","article-title":"Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors","volume":"33","year":"2007","journal-title":"J Cataract Refract Surg"},{"issue":"8","key":"10.1016\/j.ajo.2023.11.003_bib0014","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.jcrs.2005.07.023","article-title":"Effect of intracameral triamcinolone to control inflammation following cataract surgery","volume":"31","author":"Gills","year":"2005","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"10.1016\/j.ajo.2023.11.003_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0420.2007.01114.x","article-title":"Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification","volume":"86","author":"Karalezli","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajo.2023.11.003_bib0016","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2147\/OPTH.S247739","article-title":"Short-term non-infectious outcomes after a pars plana intravitreal antibiotic-steroid injection of triamcinolone, moxifloxacin, and vancomycin during cataract surgery versus a standard postoperative topical regimen","volume":"14","author":"Haq","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.11.003_bib0017","doi-asserted-by":"crossref","first-page":"92","DOI":"10.47391\/JPMA.5207","article-title":"Efficacy and safety of intravitreal injection of triamcinolone-moxifloxacin after cataract surgery in a low to middle income country - a one-year audit","volume":"73","author":"Jeeva","year":"2023","journal-title":"J Pak Med Assoc"},{"issue":"6","key":"10.1016\/j.ajo.2023.11.003_bib0018","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jcrs.2018.12.019","article-title":"Comparative analysis of intravitreal triamcinolone acetonide-moxifloxacin versus standard perioperative eyedrops in cataract surgery","volume":"45","author":"Nassiri","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ajo.2023.11.003_bib0019","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4857696","article-title":"Comparative outcomes of standard perioperative eye drops, intravitreal triamcinolone acetonide-moxifloxacin, and intracameral dexamethasone-moxifloxacin-ketorolac in cataract surgery","volume":"2022","author":"Kuriakose","year":"2022","journal-title":"J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2023.11.003_bib0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/jop.2019.0097","article-title":"Transzonular triamcinolone-moxifloxacin versus topical drops for the prophylaxis of postoperative inflammation after cataract surgery","volume":"35","author":"Singhal","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajo.2023.11.003_bib0021","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2147\/OPTH.S260926","article-title":"Comparing combination drop therapy to a standard drop regimen after routine cataract surgery","volume":"14","author":"Solomon","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2023.11.003_bib0022","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/j.jcrs.0000000000000963","article-title":"Safety and efficacy of topical vs intracanalicular corticosteroids for the prevention of postoperative inflammation after cataract surgery","volume":"48","author":"Lu","year":"2022","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ajo.2023.11.003_bib0023","first-page":"653","article-title":"Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime","volume":"91","author":"Meredith","year":"1993","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2023.11.003_bib0024","first-page":"1209","article-title":"Non steroidal anti-inflammatory drugs in the prevention of cystoid macular edema after uneventful cataract surgery","volume":"8","author":"Quintana","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2023.11.003_bib0025","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ophtha.2015.10.001","article-title":"Risk factors and incidence of macular edema after cataract surgery: a database study of 81984 eyes","volume":"123","author":"Chu","year":"2016","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2023.11.003_bib0026","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/bjo.70.6.411","article-title":"Use of a grading system in the evaluation of complications in a randomised controlled trial on cataract surgery","volume":"70","year":"1986","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2023.11.003_bib0027","first-page":"746","article-title":"Effects of cycloplegia and iris pigmentation on postoperative intraocular inflammation","volume":"24","author":"Onodera","year":"1993","journal-title":"Ophthalmic Surg"},{"issue":"7","key":"10.1016\/j.ajo.2023.11.003_bib0028","first-page":"3348","article-title":"Effects of iris pigmentation on degree of anterior chamber inflammation after cataract surgery using automated analysis by spectral domain optical coherence tomography","volume":"63","author":"Karthik","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2023.11.003_bib0029","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/bjo.86.12.1380","article-title":"Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery","volume":"86","author":"Laurell","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2023.11.003_bib0030","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ajo.2004.06.067","article-title":"Intravitreal triamcinolone acetonide and intraocular pressure","volume":"138","author":"Smithen","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.11.003_bib0031","first-page":"139","article-title":"Intraocular pressure elevation after intravitreal triamcinolone acetonide injection: a meta-analysis","volume":"9","author":"Yuksel-Elgin","year":"2016","journal-title":"Int J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2023.11.003_bib0032","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jcrs.2018.05.015","article-title":"Randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS premed study report 2","volume":"44","author":"Wielders","year":"2018","journal-title":"J Cataract Refract Surg"},{"issue":"12","key":"10.1016\/j.ajo.2023.11.003_bib0033","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1136\/bjophthalmol-2016-309838","article-title":"The UK diabetic retinopathy electronic medical record (UK DR EMR) users group, report 2: real-world data for the impact of cataract surgery on diabetic macular oedema","volume":"101","author":"Denniston","year":"2017","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2023.11.003_bib0034","first-page":"2431","article-title":"A further look at the effects of intravitreal triamcinolone acetonide on intraocular pressure in treatment of macular edema","volume":"60","author":"Mehta","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2023.11.003_bib0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12886-017-0405-7","article-title":"Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo","volume":"17","author":"McCafferty","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2023.11.003_bib0036","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.ophtha.2015.08.024","article-title":"Comparative effectiveness of three prophylactic strategies to prevent clinical macular edema after phacoemulsification surgery","volume":"122","author":"Shorstein","year":"2015","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2023.11.003_bib0037","first-page":"4794","article-title":"Outcomes after intravitreal antibiotic-steroid injection during femtosecond-laser assisted cataract surgery","volume":"59","author":"Haq","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2023.11.003_bib0038","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0161-6420(98)99053-4","article-title":"Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery","volume":"105","author":"Flach","year":"1998","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2023.11.003_bib0039","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jcrs.2007.07.017","article-title":"Ketorolac tromethamine ls 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial","volume":"33","author":"Duong","year":"2007","journal-title":"J Cataract Refract Surg"},{"issue":"14","key":"10.1016\/j.ajo.2023.11.003_bib0040","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1517\/14656560903188425","article-title":"Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent","volume":"10","author":"Jones","year":"2009","journal-title":"Expert Opin Pharmacother"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423004592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423004592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T04:54:59Z","timestamp":1718945699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423004592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":40,"alternative-id":["S0002939423004592"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.11.003","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninfectious Outcomes of Intravitreal Antibiotic Steroid Injection and Topical Nonsteroidal Antiinflammatory Drugs Versus Triple Drop Therapy After Cataract Surgery","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}